Ocera Therapeutics Receives $20,000,000 New Funding

  • Feed Type
  • Date
    8/3/2015
  • Company Name
    Ocera Therapeutics
  • Mailing Address
    525 University Avenue Palo Alto, CA 94301 USA
  • Company Description
    Ocera Therapeutics Inc. founded in January 2005, is a privately held, clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for gastrointestinal and liver diseases.
  • Website
    http://www.ocerainc.com
  • Transaction Type
    Debt
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Ocera intends to use the capital to support development of its OCR-002 molecule to treat acute and chronic patients with hepatic encephalopathy.
  • M&A Terms
  • Venture Investor
    Oxford Finance
  • Venture Investor
    Silicon Valley Bank

Trending on Xconomy